Connect CREnews
Danish Biopharma Firm to Relocate U.S. Headquarters to Boston Area
Danish biopharmaceutical firm H. Lundbeck A/S, which focuses on brain health, said Friday it will establish an innovation hub in Greater Boston and relocate its U.S. headquarters to the region from Deerfield, IL. The transition will occur over the next year. “The US has been an important driver of Lundbeck’s commercial progress and remains central ...
The post Danish Biopharma Firm to Relocate U.S. Headquarters to Boston Area appeared first on Connect CRE.